Zulfiqar Abrar-Ahmad
Service de Médecine Interne, Diabète et Maladies Métaboliques de la Clinique Médicale B, Hôpitaux Universitaires de Strasbourg et Equipe EA 3072 "Mitochondrie, Stress Oxydant et Protection Musculaire", Faculté de Médecine, Université de Strasbourg, 67000 Strasbourg, France.
Medicines (Basel). 2021 Sep 3;8(9):51. doi: 10.3390/medicines8090051.
Frailty scales are used very rarely by general practitioners as they are time consuming and are not well-adapted to current needs. Thus, we have designed with general practitioners a new scale for the early and rapid detection of frailty syndrome, called the simplified Zulfiqar Frailty Scale (sZFS).
This scale was tested in two general medicine practices in Normandy (France) for a total of six months and compared to the GFST tool "The Gerontopole Frailty Screening Tool". Only patients who were over 65 years old with an ADL ≥ 4/6 were included.
107 were patients included in the general medicine practice, with an average age of 74 years. The sZFS questionnaire has a shorter administration time than the GFST questionnaire ( < 0.001). Its sensitivity is of 93%, and its specificity is 58%. Its positive predictive value is 57%, and its negative predictive value is 93%. The area under the curve of the sZFS scale is 0.83 [0.76; 0.91] (IC95%).
Our frailty screening scale is simple, relevant, and quick.
全科医生很少使用衰弱量表,因为它们耗时且不太适应当前需求。因此,我们与全科医生共同设计了一种新的用于早期快速检测衰弱综合征的量表,称为简化的祖尔菲卡尔衰弱量表(sZFS)。
该量表在法国诺曼底的两家全科医疗诊所进行了为期六个月的测试,并与GFST工具“老年医学中心衰弱筛查工具”进行了比较。仅纳入年龄超过65岁且日常生活活动能力(ADL)≥4/6的患者。
共有107名患者纳入全科医疗诊所,平均年龄为74岁。sZFS问卷的施测时间比GFST问卷短(<0.001)。其敏感性为93%,特异性为58%。其阳性预测值为57%,阴性预测值为93%。sZFS量表的曲线下面积为0.83 [0.76; 0.91](95%置信区间)。
我们的衰弱筛查量表简单、相关且快速。